- Home
- MIST vs ANIX Comparison
MIST vs ANIX Comparison
Compare MIST & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- ANIX
- Stock Information
- Founded
- MIST 2003
- ANIX 1982
- Country
- MIST Canada
- ANIX United States
- Employees
- MIST N/A
- ANIX N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- MIST Health Care
- ANIX Health Care
- Exchange
- MIST Nasdaq
- ANIX Nasdaq
- Market Cap
- MIST 100.3M
- ANIX 82.7M
- IPO Year
- MIST N/A
- ANIX 1987
- Fundamental
- Price
- MIST $1.98
- ANIX $2.41
- Analyst Decision
- MIST Strong Buy
- ANIX Strong Buy
- Analyst Count
- MIST 3
- ANIX 2
- Target Price
- MIST $13.00
- ANIX $8.50
- AVG Volume (30 Days)
- MIST 636.8K
- ANIX 121.1K
- Earning Date
- MIST 11-12-2024
- ANIX 01-10-2025
- Dividend Yield
- MIST N/A
- ANIX N/A
- EPS Growth
- MIST N/A
- ANIX N/A
- EPS
- MIST N/A
- ANIX N/A
- Revenue
- MIST N/A
- ANIX N/A
- Revenue This Year
- MIST N/A
- ANIX N/A
- Revenue Next Year
- MIST N/A
- ANIX N/A
- P/E Ratio
- MIST N/A
- ANIX N/A
- Revenue Growth
- MIST N/A
- ANIX N/A
- 52 Week Low
- MIST $1.12
- ANIX $2.07
- 52 Week High
- MIST $2.75
- ANIX $5.09
- Technical
- Relative Strength Index (RSI)
- MIST 49.21
- ANIX 44.08
- Support Level
- MIST $1.92
- ANIX $2.07
- Resistance Level
- MIST $2.07
- ANIX $2.69
- Average True Range (ATR)
- MIST 0.20
- ANIX 0.19
- MACD
- MIST -0.03
- ANIX 0.03
- Stochastic Oscillator
- MIST 9.41
- ANIX 54.84
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.